"Small-molecule" drugs are up for price caps nine years after hitting the market, versus 13 for large-molecule biologics. This discrepancy could wallop cancer research. It can take drugmakers 15 ...
That prospect is already chilling investment in drug research, particularly in small-molecule drugs. This category of medicines, which are generally chemically synthesized, includes everything ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback